RSS

eye drop

The US Food and Drug Administration (FDA) has approved the first drug — Oxervate (cenegermin) to Dompé farmaceutici SpA — for neurotrophic keratitis, which is a rare eye disease that affects the cornea. Read more

News

Scientists from the University of Birmingham have taken a further step in their research, developing an eye drop that could be a paradigm shift in the treatment arsenal for age-related macular degeneration (AMD). Read more

News

Italian pharmaceutical company, NTC, has entered into a commercial partnership with Santen Pharmaceutical — a pharma company focused on ophthalmology. Read more

News

A type of eye drop has been developed by scientists at the University of Birmingham, UK, for the treatment of age-related macular degeneration (AMD), which is a leading cause of blindness. Read more

News